Susan Shenoi
Overview
Explore the profile of Susan Shenoi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1029
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhai S, Palermo T, Shenoi S, Demiris G, Howard W, Kientz J, et al.
J Clin Sleep Med
. 2025 Mar;
PMID: 40051205
Study Objectives: To describe the feasibility, acceptability, and preliminary efficacy of a pilot randomized controlled trial of a sleep health intervention (SLEEPSMART) for children with juvenile idiopathic arthritis (JIA) and...
2.
Toor K, Chen A, Cabral D, Mammen C, Bosman E, Shen Y, et al.
Arthritis Rheumatol
. 2024 Dec;
PMID: 39624015
Objective: We aimed to study the disease course, outcomes, and predictors of outcome in pediatric-onset antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) affecting the kidneys. Methods: Patients eligible for this study...
3.
Gagne S, Sivaraman V, Bosman E, Klamer B, Morishita K, Huber A, et al.
Arthritis Care Res (Hoboken)
. 2024 Oct;
PMID: 39467015
Objective: Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are chronic life-threatening vasculitides requiring substantial immunotherapy. Adult trials identified rituximab (RTX) as an alternative to cyclophosphamide (CYC) for remission induction...
4.
Saper V, Tian L, Verstegen R, Conrad C, Cidon M, Hopper R, et al.
J Allergy Clin Immunol Pract
. 2024 Jul;
12(11):2996-3013.e7.
PMID: 39002722
Background: After introducing IL-1/IL-6 inhibitors, some patients with Still and Still-like disease developed unusual, often fatal, pulmonary disease. This complication was associated with scoring as DReSS (drug reaction with eosinophilia...
5.
Koester S, Chow A, Pepper-Tunick E, Lee P, Eckert M, Brenchley L, et al.
Sci Rep
. 2024 Jul;
14(1):16158.
PMID: 38997299
Juvenile dermatomyositis (JDM) is a rare immune-mediated disease of childhood with putative links to microbial exposures. In this multi-center, prospective, observational cohort study, we evaluated whether JDM is associated with...
6.
Tarvin S, Sherman M, Kim H, Balmuri N, Brown A, Chow A, et al.
Arthritis Care Res (Hoboken)
. 2024 Jun;
76(11):1532-1539.
PMID: 38937134
Objective: The objective was to develop consensus treatment plans (CTPs) for patients with refractory moderately severe juvenile dermatomyositis (JDM) treated with biologic disease-modifying antirheumatic drugs (bDMARDs). Methods: The Biologics Workgroup...
7.
Balay-Dustrude E, Weiss N, Sutton A, Shenoi S
ACR Open Rheumatol
. 2024 Jun;
6(8):489-496.
PMID: 38885948
Objective: Identification of characteristics associated with active disease in juvenile idiopathic arthritis (JIA) could inform early disease treatment strategies. This study evaluated characteristics associated with active disease at 12 and...
8.
Azevedo S, Valenzuela A, Benitez C, Isenberg D, Naddaf E, Chinoy H, et al.
Ann Rheum Dis
. 2024 Mar;
83(11):e22.
PMID: 38548314
No abstract available.
9.
Lanis A, Alexanderson H, Ardalan K, Edison S, Graham C, de Groot I, et al.
Clin Exp Rheumatol
. 2024 Mar;
42(2):413-424.
PMID: 38488093
Psychological and emotional well-being are critical aspects of overall health for individuals with chronic rheumatologic conditions. Mental health-related literature, however, predominantly focuses on systemic lupus erythematosus or rheumatoid arthritis, with...
10.
Lanis A, Kim H, Lu S, Tsai W, Kaneshiro A, Ehrlich A, et al.
JAAD Case Rep
. 2024 Feb;
45:24-26.
PMID: 38379881
No abstract available.